Skip to content

Author

Zyad Algolkhof

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Efficacy and safety of minocycline in acute ischemic stroke: an updated systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

It is suggested that minocycline is biologically credible, but it did not demonstrate a consistent benefit in functional or neurological outcomes after AIS, and minocycline is viewed as a promising adjunct that now needs better targeted, biomarker-informed, reperfusion-aware trials rather than immediate universal use i...

M. Altaha, A. Abobaker, Muath Almuhanna et al. · 0 citations
Review 2026

Finerenone and cardiorenal outcomes in diabetic kidney disease: a systematic review and meta-analysis of randomized controlled trial evidence

Among patients with type 2 diabetes (T2D), diabetic kidney disease (DKD) ranks among the foremost drivers of end-stage kidney disease and cardiovascular illness. Finerenone, a selective, nonsteroidal antagonist of the mineralocorticoid receptor, has been positioned as an agent that protects both heart and kidney. This...

H. Awaji, Abubakr Bajaber, Abdullah Nebaihi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.